Founded by Flagship Pioneering, Cellarity is the first company developing medicines through an understanding of cell behaviors. The company’s broad platform harnesses single-cell technologies and machine learning to digitize and quantify cellular behaviors, unravel the network dynamics that govern those behaviors, and generate medicines that can direct them. Cellarity is using its platform to design medicines targeting the full cellular and molecular complexity of disease, enabling a quantum leap in the success rate and speed of drug discovery.
Location: United States, Massachusetts, Cambridge
Employees: 51-200
Total raised: $121M
Founded date: 2017
Investors 1
| Date | Name | Website |
| 26.02.2021 | Ahren Inno... | ahreninnov... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 04.10.2022 | Series C | $121M | - |
Mentions in press and media 5
| Date | Title | Description | Source |
| 10.01.2023 | The billionaire CEO of a top biotech VC firm details how a n... | Flagship Pioneering CEO Noubar Afeyan. Flagship Pioneering Artificial intelligence has the power to... | businessin... |
| 07.11.2022 | Class of 2023 | From day one, Contrary’s mission has been to identify the brightest, scrappiest, and most talented b... | contrary.c... |
| 04.10.2022 | Cellarity Closes $121M Series C Financing | Cellarity, a Somerville, MA-based life sciences company, raised $121M in Series C funding. The roun... | finsmes.co... |
| 25.02.2021 | Cellarity nets $123M to drive cell behavior pipeline toward ... | New approach to drug design, check. New CEO, check. Now, Cellarity is raising $123 million in ventur... | fiercebiot... |
| - | Cellarity | “Cellarity ” | fastfounde... |